As founder and CEO of Nyoo Health, Priya Bathija encourages healthcare leaders to ask questions, starting with, “How does this impact women differently?” Nyoo Health helps leaders align, inspire and execute initiatives that strengthen women’s health services and position their organizations at the forefront of care. In this conversation with McGuireWoods’ Micaela Enger and
Healthcare & Life Sciences Private Equity Deal Tracker: InTandem Invests in The Phia Group
InTandem Capital Partners has announced it has completed an investment in The Phia Group.
The Phia Group, founded in 2000 and based in Canton, Massachusetts, is the developer of cost containment and compliance solutions for health plan sponsors and employers.
InTandem, founded in 2011 and based in New York, focuses on acquiring middle…
WindRose Closes New Fund With $2.6 Billion
WindRose Health Investors has announced the closing of its seventh fund.
The fund, WindRose Health Investors VII, closed with $2.6 billion in commitments.
Fund VII, which closed at its hard cap, is targeting 11–13 investments.
WindRose, founded in 2000 and based in New York, pursues equity investments in healthcare companies. The firm invests in…
What’s Next in the Psychedelics Market, With Matt Brockmeier and Rebecca Nicholson
A range of new mental health treatments are available to Western medicine, and practitioners are figuring out how to use them effectively. Matt Brockmeier, co-founder and chief legal officer at Entheogyn and of counsel at Antithesis Law, joins Rebecca Nicholson, foundation director and wellness advisor at Prime Quadrant, to explore this evolving…
Healthcare & Life Sciences Private Equity Deal Tracker: Patient Square Acquires Premier
Patient Square Capital has announced its acquisition of Premier Inc.
Premier, formed in 1996 and based in Charlotte, North Carolina, is a healthcare service company well known for its group purchasing organization services, but also offering technology, data analytics, advisory and performance improvement solutions.
Patient Square, based in Menlo Park, Calif., is dedicated…
The Breach That Won’t Die: Navigating Post-Closing Conduct and RWI Coverage Disputes
Representations and warranties insurance (RWI) has become a fixture in today’s M&A landscape, offering buyers and sellers a mechanism to shift risk and streamline negotiations. Yet, as the RWI market matures, certain recurring disputes highlight the friction between deal economics, coverage intent, and post-closing realities. One common dispute arises when a pre-closing breach continues after the Closing date, raising the thorny question: when does loss stem from a covered pre-closing breach, and when is it attributable to post-closing conduct that falls outside the policy?
Healthcare & Life Sciences Private Equity Deal Tracker: Vance Street Acquires Injectech
Vance Street Capital has announced its acquisition of Injectech from The West Group (TWG).
Injectech, founded in 1998 and based in Fort Collins, Colorado, is a manufacturer of luer locks, bond-in luers, check valves, tube to tube connectors and spikes for the medical industry.
Vance Street, founded in 2007 and based in Los…
Healthcare & Life Sciences Private Equity Deal Tracker: H.I.G. Capital Invests in GT Independence
H.I.G. Capital has announced an investment in GT Independence.
GT, founded in 2004 and based in Sturgis, Michigan, is a provider of long-term home care and support solutions for Medicaid participants.
H.I.G., founded in 1993 and based in Miami, pursues a wide range of investments in healthcare and many other industries. The firm…
SEC Voluntarily Dismisses Landmark Enforcement Action Against SolarWinds and its CISO
On November 20, 2025, the Securities and Exchange Commission and defendants SolarWinds Corp. and Timothy G. Brown filed a joint stipulation to dismiss with prejudice the SEC’s civil enforcement action pending in the Southern District of New York. The SEC would dismiss all claims concerning the conduct alleged in the SEC’s Amended Complaint and includes broad waivers and releases by the defendants of any related claims against the SEC and its personnel. This follows a July 2, 2025 letter to the court that stated that the parties had reached a settlement in principle, and sought time “to finalize the paperwork for the settlement, and for the Commissioners to then consider and determine whether to approve the settlement.” The stipulated dismissal does not address what may have changed, and why the matter ultimately resolved through a dismissal rather than a settlement.
Healthcare & Life Sciences Private Equity Deal Tracker: Sheridan Sells Tarrytown Expocare to Carlyle
Sheridan Capital Partners has sold Tarrytown Expocare Pharmacy to Carlyle, according to a news release.
Tarrytown, founded in 2007 and based in Austin, Texas, is a long-term care pharmacy specialized in serving individuals with intellectual and developmental disabilities. The company states that it is licensed in more than 40 states.
Sheridan, founded…